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Abstract:  The  metabolic  function  of  inner  retinal  cells  relies  on  the 
availability  of  nutrients  and  oxygen  that  are  supplied  by  the  retinal 
circulation.  Assessment  of  retinal  tissue  vitality  and  function  requires 
knowledge  of  both  the  rate  of  oxygen  delivery  and  consumption.  The 
purpose of the current study is to report a novel technique for assessment of 
the  inner  retinal  metabolic  rate  of  oxygen  (MO2)  by  combined 
measurements of retinal blood flow and vascular oxygen tension (PO2) in 
rat.  The  application  of  this  technology  has  the  potential  to  broaden 
knowledge  of  retinal  oxygen  dynamics  and  advance  understanding  of 
disease pathophysiology. 
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1. Introduction 
The  function  of  retinal  tissue  can  be  adversely  affected  by  inadequate  delivery  and/or 
consumption  of  oxygen.  Derangements  in  retinal  oxygenation  are  thought  to  contribute 
significantly to the development of vision threatening eye diseases, including retinal vascular 
occlusion, diabetic retinopathy, retinopathy of prematurity, and glaucoma [1–4]. However, 
thus  far,  fundamental  mechanisms  that  implicate  oxygen  in  the  development  of  retinal 
pathologies and impairment of retinal function are not completely understood. This is in part 
because measurement of oxygen consumption of the inner retina in vivo has been challenging. 
The oxygen-sensitive microelectrode technique has provided direct measurements of inner 
retinal oxygen tension (PO2) and oxygen consumption in the rat [5], though the assumption of 
one  dimensional  oxygen  diffusion  gradients  from  the  retinal  capillaries  for  estimation  of 
oxygen  consumption  may  not  be  valid.  To  circumvent  the  complicated  three-dimensional 
oxygen diffusion gradients, inner retinal oxygen consumption has been estimated by occlusion 
of  the  retinal  vascular  supply  and  inspiration  of  100%  oxygen  [6–8].  However,  these 
measurements may not accurately reflect oxygen consumption under a normal physiological 
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manner. Magnetic resonance imaging has provided measurements of retinal oxygenation in 
response to hyperoxic inhalation challenge, though with limited depth resolution for isolating 
the inner retinal response [9,10]. Cell labeling and microsphere imaging methods in animals 
[11–14] and Doppler velocimetry techniques in humans [15–18] have measured retinal blood 
flow,  providing  only  limited  information  about  the  retinal  oxygen  metabolic  function. 
Combined blood flow and oxygen saturation (SO2) measurements for estimating metabolic 
rate of oxygen (MO2) have been reported in human retina [19], and more recently in human 
brain and  mouse ear [20,21]. We report an optical imaging technique  for assessing inner 
retinal MO2 of rat by combined measurements of retinal blood flow and vascular PO2. 
2. Methods 
2.1. Metabolic Rate of Oxygen 
Inner retinal MO2 can be calculated from retinal blood flow and vascular oxygen content 
measurements, according to Fick’s principle [22]: 
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where Fvi is the blood flow in the i
th of n veins, O2a is the oxygen (O2) content of arterial 
blood, and O2vi is the O2 content of blood in the i
th vein. It was assumed O2a is the same in all 
retinal arteries, and the total arterial and venous blood flows are identical. Blood flow was 
measured in veins because they are less affected by pulsation and have larger diameters as 
compared to arteries. Inner retinal MO2 was measured both globally and locally for assessing 
the function of the entire retinal tissue (perfused by all retinal capillaries) and a region of 
retinal tissue near the optic disc (perfused by capillaries draining into several adjacent smaller 
veins (venules)), respectively. Global inner retinal MO2 was derived by measuring PO2 in all 
major retinal arteries and veins around the optic disc and F in all major retinal veins. Local 
inner retinal MO2 was determined based on measurements of PO2 in the major feeding artery, 
coupled with PO2 and F measured in smaller draining venules. 
2.2. Imaging 
Vascular  PO2  was  measured  using  our  optical  section  phosphorescence  lifetime  imaging 
system [23,24], which combines principles of optical sectioning and phosphorescence lifetime 
imaging. Due to an angle between the incident laser light and imaging path, phosphorescence 
from  structures  in  different  retinal  depths  were  imaged.  Phosphorescence  imaging  was 
performed in 10 anesthetized Long Evans rats following intravenous injection of an oxygen-
sensitive molecular probe (albumin bound Pd-porphine). Since phosphorescence emission was 
quenched  by  oxygen,  its  lifetime  was  a  measure  of  PO2.  Phosphorescence  lifetime  was 
determined using a frequency-domain approach that involved incrementally varying the phase 
delay between modulated laser light and camera sensitivity. Lifetime was converted to PO2 
according  to  the  Stern-Volmer  expression:  PO2  =  1/(κQ  τ)  -  1/(κQ  τ0),  where  τ  is  the 
phosphorescence lifetime, κQ is the quenching constant for the triplet-state phosphorescence 
probe, and τ0 is the lifetime in a zero oxygen environment. 
For global inner retinal MO2 calculation, PO2 was measured in major retinal arteries and 
veins around the optic nerve head from cross-sectional phosphorescence images, according to 
our previously published methodology [24]. Three repeated PO2 measurements were averaged 
in each major retinal artery and vein. For local inner retinal MO2 calculation, an enface PO2 
map of a retinal area either temporal or nasal to the optic nerve head was generated by a laser 
scan, as described in our previous publication [23]. Global and local MO2 measurements were 
obtained in 2 separate groups of 5 rats. The O2 content of blood was determined as the sum of 
oxygen bound to hemoglobin and dissolved in blood [25]. The amount of oxygen bound to 
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(based on a measured mean of 14.4 ± 0.6 g/dl in 7 rats), and the oxygen carrying capacity of 
1.39 mlO2/g [26]. SO2 was calculated from the measured PO2 and blood pH values using the 
hemoglobin dissociation curve [27]. The amount of dissolved oxygen in blood was calculated 
as the product of oxygen solubility in blood (0.003 mlO2/dl*mmHg) and PO2 measurements.. 
Blood  velocity  was  measured  by  imaging  intravascular  motion  of  fluorescent 
microspheres  [28],  within  20  minutes  of  phosphorescence  imaging.  The  method  involved 
intravenous injection of 2 micron fluorescent spheres, while the retina was imaged using a 
prototype slitlamp biomicroscope. The slitlamp was equipped with a 488 nm diode laser for 
illumination and a 560 ± 60 nm emission filter placed in front of a charge-coupled device 
camera,  which  had  high  sensitivity  and  image  acquisition  rate.  The  movement  of 
microspheres in the retinal vasculature was captured by a sequence of images acquired at a 
frame rate of 60 or 108 Hz. A higher acquisition rate was preferred for measuring higher 
blood velocity in the major retinal veins. Images were analyzed to measure the displacement 
of  microspheres  over  time  and  derive  blood  velocity  measurements.  Blood  velocity  was 
determined based on measured velocities of 4 to 47 microspheres in major retinal veins and 1 
to 10 microspheres in retinal venules. The number of microspheres visualized depended on 
the  duration  of  image  acquisition,  and  the  concentration  and  volume  of  the  injected 
microspheres, which were progressively optimized as the technique was developed. Blood 
vessel diameter was measured from red free retinal images for veins and from fluorescein 
angiograms for venules, which provided better contrast for visualization of the smaller blood 
vessels. Diameters were measured based on the full width at half maximum of an intensity 
profile of a line perpendicular to the centerline of the blood vessel, similar to our previous 
publication [29]. Blood vessel diameter was derived by averaging 3 to 38 measurements in 
major retinal veins and 2 to 19 measurements in retinal venules. The number of measurements 
was dependent on the length of the centerline that could be identified from the image of the 
blood vessel. F was calculated by the following equation: F = blood velocity*π*diameter
2/4. 
3. Results 
3.1. Global Inner Retina MO2 
Figure 1a shows an example of a retinal image acquired in one rat, with major retinal arteries 
and  veins  labeled.  An  example  of  a  retinal  vein  with  edges  outlined  based  on  multiple 
diameter measurements is shown. The locations of a single microsphere traversing a major  
 
 
Fig. 1. (a) Retinal image with major arteries and veins labeled (a and v); the outlined edges of a 
vein (v3) were identified by multiple diameter measurements; (b) Red crosses overlaid on the 
retinal image indicate the positions of a microsphere traversing a vein (v3), visualized over 8 
consecutive images; (c) A cross-sectional vascular PO2 map (rectangle) overlaid on the retinal 
image, depicting values in veins (v1, v2, v3) and arteries (a2, a3). Color bar displays PO2 in 
mmHg. 
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vascular PO2 map overlaid on the retinal image is shown in Fig. 1c. Major retinal arteries and 
veins were differentiated based on the direction of F and level of PO2. 
Measured blood vessel diameter, velocity, PO2, and calculated F and O2 content of blood 
in the major retinal veins of a rat (shown in Fig. 1) are listed in Table 1. Since retinal arterial 
PO2 is assumed to be constant, an average PO2 over all major retinal arteries was calculated. 
Following Eq. (1), global inner retina MO2 was calculated to be 639 nlO2/min. Global inner 
retinal MO2 in rats was on average 499 ± 117 nlO2/min (N = 5). 
For global MO2 measurements, the standard deviations (SD) of repeated vessel diameter, 
blood velocity, and PO2 measurements in the major retinal blood vessels were on average 3 
microns, 6 mm/s, and 2 mmHg (N = 5), respectively. Using principles of propagation of error 
[30], the SD of MO2 was estimated to be approximately 46 nlO2/min, indicating changes of 90 
nlO2/min can be detected with 95% confidence. 
Table 1. Vessel diameter, blood velocity, and blood flow in major retinal veins; PO2 and 
O2 content in major retinal veins and averaged over major retinal arteries (mean ± SD) in 
one rat 
Blood Vessel 
Diameter 
( m) 
Velocity 
(mm/s) 
Flow 
(µl/min) 
PO2 
(mmHg) 
O2 Content 
(mlO2/dl) 
Arteries           42 ± 2  11.1 ± 0.6 
Vein 1  42  13  1.1  25  5.0 
Vein 2  49  11  1.3  26  5.4 
Vein 3  67  13  2.7  27  5.6 
Vein 4  61  13  2.4  26  5.4 
Vein 5  40  9  0.7  26  5.4 
Vein 6  60  14  2.4  22  4.0 
 
Fig. 2. (a) Fluorescein angiogram with draining retinal venules labeled; edges of a venule (v1) 
are  outlined;  (b)  Red  crosses  overlaid  on  the  retinal  image  indicate  the  positions  of  a 
microsphere traversing a venule (v1) and major vein, visualized over 8 consecutive images; (c) 
An enface PO2 map depicting values in a segmented major retinal artery, vein, and venules. 
Color bar displays PO2 in mmHg. 
3.2. Local Inner Retina MO2 
Figure 2a shows an example of a fluorescein angiogram acquired in one rat, with selected 
retinal  blood  vessels  numbered  and  labeled.  The  positions  of  a  microsphere  traversing  a 
venule and a major retinal vein, overlaid on a retinal image, are shown in Fig. 2b. In Fig. 2c, 
an enface PO2 map of a segmented major retinal artery, vein, and venules displays values in 
pseudo color. 
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in retinal venules and a major retinal artery in one rat 
Blood Vessel 
Diameter 
( m) 
Velocity 
(mm/s) 
Flow 
(nl/min) 
PO2 
(mmHg) 
O2 Content 
(mlO2/dl) 
Artery        35  8.1 
Venule 1  16  4  51  22  3.5 
Venule 2  11  4  21  23  3.7 
Venule 3  16  4  44  27  5.2 
Measured  blood  vessel  diameter,  velocity  and  calculated  F  in  the  draining  venules 
connected to a major vein of one rat (shown in Fig. 2) are listed in Table 2. Measured PO2 and 
O2 content of blood in the major retinal artery and venules of the same rat are also listed in 
Table 2. PO2 in the artery supplying the retinal area was assumed to be constant and the same 
as in the branching arterioles, since the branching arterioles are directly supplied by the major 
artery. It is not valid to use PO2 in the major vein to calculate the local inner retinal MO2 
because the vein has substantial oxygen contributions from peripheral retinal tissue. Local 
inner retinal MO2 was calculated according to Eq. (1) to be 4.5 nlO2/min. The range of local 
inner retinal MO2 measurements was from 3.6 to 11.4 nlO2/min (5.1 ± 3.6 nlO2/min; N = 5). 
Local  inner  retinal  MO2  measurements  vary  among  rats  depending  on  the  volume  of  the 
retinal tissue drained by the selected venules. 
4. Discussion 
The feasibility of our methodology to measure quantitatively retinal blood flow and oxygen 
tension and to determine inner retinal metabolic rate of oxygen in rats was demonstrated. Our 
measurements  in  major  retinal  veins  were  in  agreement  with  previously  reported  blood 
velocity [11,31] and vessel diameter [32] measurements in rats. Since blood velocity was 
determined by averaging velocities of multiple microspheres in each blood vessel, it is likely a 
reasonable  estimate  of  the  mean  of  the  distribution  of  blood  velocities  that  occur  due  to 
laminar flow. PO2  measurements in retinal arteries and veins  were consistent  with  values 
obtained  with  microelectrodes  near  the  surface  of  retinal  blood  vessels  in  rats  [33].  For 
comparison to previously published studies of retinal oxygen consumption, global inner retina 
MO2 measurements obtained in the present study were divided by the estimated mass of inner 
retinal  tissue  in  rat  [34],  yielding  an  average  inner  retinal  oxygen  consumption  of  7.1 
mlO2/min*100g.  This  value  is  somewhat  higher  than  inner  retinal  oxygen  consumption 
measured by determining arteriovenous oxygen differences and blood flow in separate groups 
of  pigs  (4.6  and  3.8  mlO2/min*100g)  [35,36].  It  is  also  higher  than  inner  retinal  oxygen 
consumption measurements obtained by oxygen microelectrodes for only a selected part of 
inner retina of rat, converted to the same units (1.1 mlO2/min*100g) [5], and with retinal 
artery occlusion and 100% oxygen inspiration in cat and rat (3.7 and 2.7 mlO2/min*100g) 
[7,8]. Differences in estimated parameters, such as the mass of inner retinal tissue, may in part 
account for variations of oxygen consumption values reported by various techniques. 
In future studies, our method will allow investigation of the relationships among retinal 
blood flow, vascular oxygen levels, and oxygen consumption under normal and challenged 
physiological conditions. For example, by examining the same retinal tissue with and without 
light flicker, alterations in global and local inner retinal MO2 measurements can be evaluated. 
Such  studies  will  improve  understanding  of  neurovascular  coupling  under  a  normal 
physiological condition, as well as assessment of abnormalities due to pathological states. 
Overall,  quantitative  measurements  of  inner  retinal  MO2  have  the  potential  to  advance 
knowledge of retinal oxygen dynamics in health and disease. 
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